These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 31844005)

  • 41. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates.
    Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910898
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manogepix (APX001A) Displays Potent
    Arendrup MC; Jørgensen KM
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.
    Arendrup MC; Park S; Brown S; Pfaller M; Perlin DS
    Antimicrob Agents Chemother; 2011 May; 55(5):1891-5. PubMed ID: 21357293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.
    Dong J; Liang G; Zheng H; Kan S; Song N; Zhang M; Liu W
    Mycoses; 2021 Jun; 64(6):651-655. PubMed ID: 33609301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
    Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
    Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST).
    Pfaller MA; Messer SA; Motyl MR; Jones RN; Castanheira M
    J Antimicrob Chemother; 2013 Apr; 68(4):858-63. PubMed ID: 23190764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.
    Pfaller MA; Rhomberg PR; Messer SA; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):259-63. PubMed ID: 25600842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species.
    Astvad KM; Perlin DS; Johansen HK; Jensen RH; Arendrup MC
    Antimicrob Agents Chemother; 2013 Jan; 57(1):177-82. PubMed ID: 23089746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Echinocandin-Resistant
    Bordallo-Cardona MÁ; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.
    Larkin EL; Long L; Isham N; Borroto-Esoda K; Barat S; Angulo D; Wring S; Ghannoum M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30885896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
    Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
    J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.